Summary
- Current Price
- As of today, IBRX price is $7.57, down -1.05% in the most recent trading session on
- Current Price All-Time High
- IBRX price is currently -83.33% below its historical high of $45.42 set on
- Market Cap
- IBRX current market cap is $8B, up +223.33% over the past 365 days
- Revenue
- IBRX current annual revenue is $113.29M, up +668.31% year-over-year
- Next Earnings
- The next earnings release for IBRX is on
Profile
| Metric | Value |
|---|---|
| Full Name | ImmunityBio, Inc. |
| Ticker | NASDAQ: IBRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunitybio.com |
| Employees | 671 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $7.57 | |
| Price, 1D Change | -1.05% | |
| $8B | ||
| - | ||
| - | ||
| 1.59 | ||
| $113.29M | ||
| Revenue, 1Y Change | +668.31% | |
| -$0.38 | ||
| EPS, 1Y Change | +38.28% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | NK | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.38 | ||
| EPS Estimate | -$0.92 | N/A |
| EPS Est. Change | -139.53% | N/A |
| $113.29M | ||
| Revenue Estimate | $225.73M | N/A |
| Revenue Est. Change | +99.26% | N/A |
| Current Price | $7.57 | |
| Price Target | $12.00 | - |
| Price Tgt. Change | +58.52% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.67 | -$0.62 | +7.63% | |
| -$0.40 | -$0.38 | +5.28% | |
| -$0.92 | N/A | -139.53% | |
| -$0.13 | N/A | +66.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $21.23M | $14.75M | -30.54% | |
| $112.82M | $113.29M | +0.41% | |
| $225.73M | N/A | +99.26% | |
| $441.47M | N/A | +289.69% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $7.57 | |
| $6.16 | ||
| $7.65 | ||
| $6.48 | ||
| $7.60 | ||
| -$0.04 | ||
| 1.59 | ||
| $0.41 | ||
| 50.49 | ||
| 39.31% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $113.29M | ||
| -$0.38 | ||
| $97.01M | ||
| 85.63% | ||
| -$256.03M | ||
| -226.00% | ||
| -$351.47M | ||
| -310.25% | ||
| -$240.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -1.69 | ||
| 5.10 | ||
| 5.08 | ||
| - | ||
| 4 | ||
| -6.44 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$500.47M | ||
| $242.82M | ||
| $501.90M | ||
| $314.88M | ||
| $1.00B | ||
| $61.75M | ||
| $844.67M | ||
| $9.29M | ||
| $6.98M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $464.69M | ||
| $353.04M | ||
| $16.28M | ||
| $0.00 | ||
| $15.53M | ||
| $0.00 | ||
| -$135.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$304.94M | ||
| -$149.80M | ||
| $400.24M | ||
| $4.25M | ||
| -$309.19M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with IBRX
FAQ
- What is the ticker symbol for ImmunityBio, Inc.?
- The ticker symbol for ImmunityBio, Inc. is NASDAQ:IBRX
- Does ImmunityBio, Inc. pay dividends?
- No, ImmunityBio, Inc. does not pay dividends
- What sector is ImmunityBio, Inc. in?
- ImmunityBio, Inc. is in the Healthcare sector
- What industry is ImmunityBio, Inc. in?
- ImmunityBio, Inc. is in the Biotechnology industry
- What country is ImmunityBio, Inc. based in?
- ImmunityBio, Inc. is headquartered in United States
- When did ImmunityBio, Inc. go public?
- ImmunityBio, Inc. initial public offering (IPO) was on July 28, 2015
- Is ImmunityBio, Inc. in the S&P 500?
- No, ImmunityBio, Inc. is not included in the S&P 500 index
- Is ImmunityBio, Inc. in the NASDAQ 100?
- No, ImmunityBio, Inc. is not included in the NASDAQ 100 index
- Is ImmunityBio, Inc. in the Dow Jones?
- No, ImmunityBio, Inc. is not included in the Dow Jones index
- When was ImmunityBio, Inc. last earnings report?
- ImmunityBio, Inc.'s most recent earnings report was on August 4, 2026
- When does ImmunityBio, Inc. report earnings?
- The next expected earnings date for ImmunityBio, Inc. is November 3, 2026
Data Sources & References
- IBRX Official Website immunitybio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1326110/000132611026000030/0001326110-26-000030-index.htm
- IBRX Profile on Yahoo Finance finance.yahoo.com/quote/IBRX
- IBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ibrx